Chronic Kidney Disease (CKD) and Hypertension Essentials 2011
The World's Leading Experts Provide all the 'Essentials' Needed to Manage Patients in the Office and on the Ward! Nearly 17% of adults in the United States have Chronic Kidney Disease (CKD), and one of the most common causes of CKD is hypertension. Treatment of hypertension has become the most important intervention in the management of all forms of Chronic Kidney Disease. Chronic Kidney Disease (CKD) and Hypertension Essentials is a current, concise, and practical step-by-step guide to the identification, treatment and management of hypertension in patients with CKD. This quick reference is an ideal resource for primary care physicians, cardiologists, nephrologists and physicians in training.
What people are saying - Write a review
We haven't found any reviews in the usual places.
CHAPTER 2 EPIDEMIOLOGY OF HYPERTENSION IN CHRONIC KIDNEY DISEASE
CHAPTER 3 ASSESSMENT OF THE HYPERTENSIVE PATIENT FOR KIDNEY DISEASE
CHAPTER 4 SECONDARY AND RESISTANT HYPERTENSION
CHAPTER 5 HYPERTENSION IN END STAGE RENAL DISEASE
CHAPTER 6 APPROACHES TO HYPERTENSION IN CHRONIC KIDNEY DISEASE
ACE inhibitors adults agents albuminuria aliskiren ambulatory blood pressure amlodipine angiotensin-converting enzyme antihypertensive associated Bakris baseline beta-blockers Bomback cardiovascular disease cardiovascular events cardiovascular risk chlorthalidone chronic kidney disease CKD patients Clin combination therapy cystatin dialysis patients diastolic diastolic blood pressure diet dietary diuretics dose drugs effects eGFR elevated end stage renal EnglJ eplerenone estimated GFR Evaluation glomerular filtration rate guidelines heart failure hemodialysis hemodialysis patients hydrochlorothiazide hyperkalemia hypertensive patients increased JAMA kidney function Kidney Int left ventricular losartan lower blood pressure meta-analysis metabolic syndrome mg/day microalbuminuria mortality nebivolol Nephrol Dial Transplant nocturnal obesity patients with CKD patients with hypertension placebo plasma prevalence progression proteinuria RAAS blockade randomized receptor blocker reduction renal artery renal function renin renovascular resistant hypertension risk factors salt serum creatinine Soc Nephrol sodium spironolactone stage renal disease systolic blood pressure treatment type 2 diabetes vascular weight loss